Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India
· Delayed Price · Currency is INR 1,778.70
+31.40 (1.80%)
Apr 29, 2026, 3:30 PM IST
NSE:SUNPHARMA Revenue
Sun Pharmaceutical Industries had revenue of 155.21B INR in the quarter ending December 31, 2025, with 13.49% growth. This brings the company's revenue in the last twelve months to 568.09B, up 10.09% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.
Revenue (ttm)
568.09B
Revenue Growth
+10.09%
P/S Ratio
7.38
Revenue / Employee
13.21M
Employees
43,000
Market Cap
4,192.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
| Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
| Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
| Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
| Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Divi's Laboratories | 103.14B |
| Cipla | 279.67B |
| Mankind Pharma | 139.14B |
| Zydus Lifesciences | 260.89B |
| Aurobindo Pharma | 331.82B |
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Laurus Labs | 67.22B |
Sun Pharmaceutical Industries News
- 1 day ago - How Sun Pharma’s U.S. buy could spur other Indian pharma firms' global expansion - CNBC
- 1 day ago - Sun Pharma sees Rs 24 crore block deal as 139,060 shares change hands - Business Upturn
- 1 day ago - Sun Pharma buys US-based Organon for $12 billion in biggest-ever overseas pharma deal - The Times of India
- 1 day ago - Gujarat’Sun Pharma to acquire Organon in $11.8bn all-cash deal - The Times of India
- 1 day ago - Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal - The Motley Fool
- 1 day ago - Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal - The Wall Street Journal
- 2 days ago - Sun Pharmaceutical (SUNPHARMA) Acquires Oganon for $11.75 Billion in Cash - GuruFocus
- 2 days ago - Indian Shares Climb On Firm Global Cues; Sun Pharma Shares Rally 7% - Nasdaq